Increased spontaneous release of tumour necrosis factor-alpha by alveolar macrophages from wheezy infants

We determined if alveolar macrophages (AMs) from infants with severe recurrent wheezing episodes release increased amounts of tumour necrosis factor-alpha (TNF-alpha), as described in adults with asthma. We compared TNF-alpha release by unstimulated and lipopolysaccharide-stimulated AMs obtained by bronchoalveolar lavage in 13 wheezy and seven nonwheezy infants (aged 6-36 months) and analysed its regulation by dexamethasone. Metabolites in cell supernatants were quantified by enzyme-linked immunosorbent assay (ELISA) (TNF-alpha) or radioimmunoassay (thromboxane B2 and prostaglandin E2). Comparison of results was performed by the Mann-Whitney U-test and values were expressed as median (interquartile range) in ng x 10(6) cells(-1). Resting AMs from wheezy infants released larger amounts of TNF-alpha and thromboxane B2 as compared to controls: 2.67 (0.89-8.33) vs 0.48 (0.25-1.08) and 75.63 (38.07-158.91) vs 10.03 (7.36-76.08), respectively (p<0.05). When stimulated overnight with bacterial lipopolysaccharide, AMs from both groups released similar amounts of metabolites. Dexamethasone induced a consistent inhibition of the lipopolysaccharide-stimulated release of all the mediators. Our results show that alveolar macrophages from wheezy infants are activated to release increased amounts of tumour necrosis factor-alpha, as in asthma, and suggest that infants with recurrent wheezing may eventually benefit from treatment with glucocorticoids.

This article has been cited by other articles:

				C M McDougall and P J Helms Neutrophil airway inflammation in childhood asthma Thorax, September 1, 2006; 61(9): 739 - 741. [Full Text] [PDF]

				B. Mahut, C. Delacourt, F. Zerah-Lancner, J. De Blic, A. Harf, and C. Delclaux Increase in Alveolar Nitric Oxide in the Presence of Symptoms in Childhood Asthma Chest, March 1, 2004; 125(3): 1012 - 1018. [Abstract] [Full Text] [PDF]

				M. Le Bourgeois, M. Goncalves, L. Le Clainche, M.-R. Benoist, J.-C. Fournet, P. Scheinmann, and J. de Blic Bronchoalveolar Cells in Children < 3 Years Old With Severe Recurrent Wheezing* Chest, September 1, 2002; 122(3): 791 - 797. [Abstract] [Full Text] [PDF]

				G. Cheng, T. Ueda, F. Eda, M. Arima, N. Yoshida, and T. Fukuda A549 Cells Can Express Interleukin-16 and Stimulate Eosinophil Chemotaxis Am. J. Respir. Cell Mol. Biol., August 1, 2001; 25(2): 212 - 218. [Abstract] [Full Text] [PDF]

				E. Sato, D. K. Nelson, S. Koyama, J. C. Hoyt, and R. A. Robbins Erythromycin Modulates Eosinophil Chemotactic Cytokine Production by Human Lung Fibroblasts in Vitro Antimicrob. Agents Chemother., February 1, 2001; 45(2): 401 - 406. [Abstract] [Full Text]

				K. Le-Barillec, D. Pidard, V. Balloy, and M. Chignard Human neutrophil cathepsin G down-regulates LPS-mediated monocyte activation through CD14 proteolysis J. Leukoc. Biol., August 1, 2000; 68(2): 209 - 215. [Abstract] [Full Text]

				C. A. JONES and P. G. HOLT Immunopathology of Allergy and Asthma in Childhood Am. J. Respir. Crit. Care Med., August 1, 2000; 162(2): S36 - 39. [Full Text] [PDF]

				O. GHAFFAR, Q. HAMID, P. M. RENZI, Z. ALLAKHVERDI, S. MOLET, J. C. HOGG, S. A. SHORE, A. D. LUSTER, and B. LAMKHIOUED Constitutive and Cytokine-Stimulated Expression of Eotaxin by Human Airway Smooth Muscle Cells Am. J. Respir. Crit. Care Med., June 1, 1999; 159(6): 1933 - 1942. [Abstract] [Full Text]

				C. MARGUET, F. JOUEN-BOEDES, T. P. DEAN, and J. O. WARNER Bronchoalveolar Cell Profiles in Children with Asthma, Infantile Wheeze, Chronic Cough, or Cystic Fibrosis Am. J. Respir. Crit. Care Med., May 1, 1999; 159(5): 1533 - 1540. [Abstract] [Full Text] [PDF]

				E. BARALDI, C. DARIO, R. ONGARO, M. SCOLLO, N. M. AZZOLIN, N. PANZA, N. PAGANINI, and F. ZACCHELLO Exhaled Nitric Oxide Concentrations during Treatment of Wheezing Exacerbation in Infants and Young Children Am. J. Respir. Crit. Care Med., April 1, 1999; 159(4): 1284 - 1288. [Abstract] [Full Text] [PDF]